GENE ONLINE|News &
Opinion
Blog

PARP Inhibitor
Regulatory PARP Inhibitor
EMA Recommends Restriction on Rubraca
2022-07-25
Trials & Approvals PARP Inhibitor
AZ, Merck’s PARP Inhibitor Shines in Phase 3 Prostate Cancer Trial
2021-09-26
China
Zai Lab, Schrödinger Collaborate to Advance Cancer Program
2021-08-05
Trials & Approvals
Clovis Oncology’s PARP Inhibitor Shines in Preliminary Prostate Cancer Trial
2021-04-12
Technology
Understanding Cancer Chromosomal Instability: Highlights from the AACR2021 Discovery Science Plenary Session
2021-04-11
Trials & Approvals PARP Inhibitor
Lynparza Bags Multiple Approvals in Japan
2021-01-05
In-Depth
Tumor Drug Resistance Helps Identify a Novel Therapy for Leukemia
2020-10-11
Trials & Approvals
#ESMO20: AZ, Merck’s PARP Inhibitor Surpasses Standard of Care in Prostate Cancer Trial
2020-09-22
Trials & Approvals Pancreatic Cancer
Lynparza Notches EU Authorization for BRCA-Mutated Metastatic Pancreatic Cancer
2020-07-11
Trials & Approvals Prostate Cancer
Lynparza Greenlighted by FDA for HRR-Mutated, Metastatic Prostate Cancer
2020-05-27
R&D
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
Technology
AACR 2020 Conference – Opening Clinical Plenary Highlights
2020-04-28
In-Depth Drug Resistance
Cancer Drug Resistance: Implications in Cancer Therapy
2020-04-20
COVID-19 PARP Inhibitor
Genentech’s Actemra gets FDA approval to begin COVID-19 Trials in April
2020-03-25
Licensing PARP Inhibitor
Japan Grants Orphan Drug Designation to Lynparza for Germline BRCA-mutated Pancreatic Cancer
2020-03-25
1 2
LATEST
NVIDIA’s Global AI Strategy: A Multi-Region Push with Taiwan and Middle East as Key Hubs
2025-05-22
MIRDC Establishes CDMO Innovation Center in Boston to Advance into Innovative Healthcare
2025-05-22
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval
2025-05-20
NIH Restores Research Funding to Previously Defunded Scientists Amid Policy Shifts
2025-05-20
Prime Medicine Reduces Workforce by 25 Percent and Appoints David Schenkein as New CEO
2025-05-20
UnitedHealth Group Stock Drops Amid Rising Medicare Advantage Costs and Regulatory Debates
2025-05-20
READ MORE
EVENT
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top